Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-24-112287
Filing Date
2024-10-29
Accepted
2024-10-29 17:19:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 POS AM tm2426916d1_posam.htm POS AM 928444
2 EXHIBIT 4.10 tm2426916d1_ex4-10.htm EX-4.10 133694
3 EXHIBIT 4.11 tm2426916d1_ex4-11.htm EX-4.11 133907
4 EXHIBIT 23.1 tm2426916d1_ex23-1.htm EX-23.1 5633
5 GRAPHIC tm2421032d1_posamimg001.jpg GRAPHIC 13718
6 GRAPHIC image_003.jpg GRAPHIC 2270
  Complete submission text file 0001104659-24-112287.txt   1225154
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-274292 | Film No.: 241406722
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)